CONCORDANCE BETWEEN PATIENTS AND CLINICIANS' REPORTING OF SYMPTOMATIC ADVERSE EVENTS IN CANCER CLINICAL TRIALS: A SYSTEMATIC REVIEW

被引:0
|
作者
Sparano, F. [1 ,2 ]
Aaronson, N. [3 ]
Cottone, F. [1 ,2 ]
Piciocchi, A. [1 ,2 ]
La Sala, E. [1 ,2 ]
Anota, A. [4 ]
Deliu, N. [1 ,2 ]
Kieffer, J. M. [3 ]
Efficace, F. [1 ,2 ]
机构
[1] Italian Grp Adult Hematol Dis GIMEMA, Ctr Data, Rome, Italy
[2] Italian Grp Adult Hematol Dis GIMEMA, Hlth Outcomes Res Unit, Rome, Italy
[3] Netherlands Canc Inst, Amsterdam, Netherlands
[4] Univ Hosp Besancon, Besancon, France
关键词
D O I
10.1016/j.jval.2018.09.450
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN368
引用
收藏
页码:S76 / S77
页数:3
相关论文
共 50 条
  • [1] Concordance between symptomatic adverse event ratings by clinicians and patients: a systematic review
    Ryan, Sean
    Atkinson, Thomas M.
    Bennett, Antonia V.
    Jewell, Sarah
    Wagner, Jan-Samuel
    Basch, Ethan
    [J]. QUALITY OF LIFE RESEARCH, 2013, 22
  • [2] Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials
    Freyer, David R.
    Lin, Li
    Mack, Jennifer W.
    Maurer, Scott H.
    McFatrich, Molly
    Baker, Justin N.
    Jacobs, Shana S.
    Lucas, Nicole
    Withycombe, Janice S.
    Tomlinson, Deborah
    Villabroza, Katie Rose
    Waldron, Mia K.
    Hinds, Pamela S.
    Reeve, Bryce B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1623 - +
  • [3] Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review
    Enrico, Diego
    Waisberg, Federico
    Burton, Jeannette
    Mando, Pablo
    Chacon, Matias
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [4] Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
    Basch, Ethan
    Dueck, Amylou C.
    Rogak, Lauren J.
    Minasian, Lori M.
    Kelly, William Kevin
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Seisler, Drew
    Atherton, Pamela J.
    Paskett, Electra
    Carey, Lisa
    Dickler, Maura
    Heist, Rebecca S.
    Himelstein, Andrew
    Rugo, Hope S.
    Sikov, William M.
    Socinski, Mark A.
    Venook, Alan P.
    Weckstein, Douglas J.
    Lake, Diana E.
    Biggs, David D.
    Freedman, Rachel A.
    Kuzma, Charles
    Kirshner, Jeffrey J.
    Schrag, Deborah
    [J]. JAMA ONCOLOGY, 2017, 3 (08) : 1043 - 1050
  • [5] Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients
    Meghelli, Leila
    Narducci, Fabrice
    Mariette, Christophe
    Piessen, Guillaume
    Vanseymortier, Marie
    Leblanc, Eric
    Collinet, Pierre
    Duhamel, Alain
    Penel, Nicolas
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 104 : 108 - 114
  • [6] Quality of reporting and concordance between sources of adverse events in the treatment of moderate to severe psoriasis: A systematic review
    Beytout, Q.
    Afach, S.
    Guelimi, R.
    Sbidian, E.
    Le Cleach, L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 : 41 - 42
  • [7] More thoughts on the reporting of adverse events in cancer clinical trials
    Extermann, Martine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 918 - 918
  • [8] Adverse events reporting in phase III oncology clinical trials of checkpoint inhibitors: A systematic review
    Joulia, M-L.
    Barhli, A.
    Tournigand, C.
    Kempf, E.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S725 - S725
  • [9] The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review
    Gorrell, Lindsay M.
    Engel, Roger M.
    Brown, Benjamin
    Lystad, Reidar P.
    [J]. SPINE JOURNAL, 2016, 16 (09): : 1143 - 1151
  • [10] Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
    Bossi, P.
    Botta, L.
    Bironzo, P.
    Sonetto, C.
    Musettini, G.
    Sbrana, A.
    Di Giannantonio, V.
    Locati, L.
    Di Maio, M.
    Antonuzzo, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27